American Board of Internal Medicine (ABIM) · January 2026 ABIM Medical Oncology Certification Examination blueprint, with the current expanded CERT outline; implemented for fall 2026 certification examinations. Verified on 2026-10-09. The workbook label 'ABIM - Subspecialty in Medical Oncology' maps to this official examination; the assigned slug is preserved.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Register, Prepare and Take Your Subspecialty Certification Exam: Medical Oncology
• Medical Oncology Blueprint for Certification Examination — January 2026
• ABIM Expanded Blueprints
• Medical Oncology Certification Examination Expanded Blueprint
• NCI: Clinical Trial Randomization
• NCI: Cancer Pain (PDQ), Health Professional Version
• NCI: Palliative Care in Cancer
• NCI: Female Fertility and Cancer
• NCI: Chronic Lymphocytic Leukemia Treatment (PDQ)
• NCI: Plasma Cell Neoplasms Treatment (PDQ)
• NCI: Chronic Myeloid Leukemia Treatment (PDQ)
• NCI: Non-Small Cell Lung Cancer Treatment (PDQ)
• NCI: Small Cell Lung Cancer Treatment (PDQ)
• NCI: Hormone Therapy for Breast Cancer
• ASCO–CAP HER2 Breast Testing Guideline Update: Summary of Recommendations
• NCI: Breast Cancer Treatment (PDQ)
• NCI: Testicular Cancer Treatment (PDQ)
• NCI: Prostate Cancer Treatment (PDQ)
• NCI: Bladder Cancer Treatment (PDQ)
• NCI: BRCA Gene Changes—Cancer Risk and Genetic Testing
• NCI: Ovarian Epithelial, Fallopian Tube and Primary Peritoneal Cancer Treatment (PDQ)
• NCI: Colon Cancer Treatment (PDQ)
• NCI: Anal Cancer Treatment (PDQ)
• NCI: Gastrointestinal Stromal Tumors Treatment (PDQ)
• NCI: Melanoma Treatment (PDQ)
• NCI: Central Nervous System Tumors Treatment (PDQ)
• FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer | FDA
• IMWG Criteria for the Diagnosis of MM | Inl Myeloma Fn
• Apperley_J.etal_Leukemia2025.2025EuropeanLeukemiaNetrecommendationsforthemanagementofchronicmyeloidleukemia.pdf
• These highlights do not include all the information needed to use HERCEPTIN safely and effectively. See full prescribing information for HERCEPTIN. HERCEPTIN® (trastuzumab) for injection, for intravenous use Initial U.S. Approval: 1998
• DailyMed - KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution KEYTRUDA- pembrolizumab injection, solution
• Treatment - EAU Guidelines on Prostate Cancer - Uroweb
• Understanding Cancer Research Consent Forms - NCI
• Molecular Testing Guideline For The Selection Of Lung Cancer Patients For Treatment With TKI - CAP
• FDA approves durvalumab for limited-stage small cell lung cancer | FDA
• International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment - PMC
• Diagnostic Evaluation - EAU Guidelines on Testicular Cancer - Uroweb
• zytiga-epar-product-information_en.pdf